All News

The authors make a case that using messengers to reach vulnerable populations isn't just a good idea. In the age of value-based reimbursement, it's becoming a necessity.

Researchers at the Medical College of Georgia show how age causes a protection against inflammation to decline.

A new report by the National Academy of Medicine explores how the healthcare system can improve care and manage costs for the 5% of high-need patients who account for almost half of the healthcare spending in the United States.

Administration officials say fewer insurers filing an intent to offer coverage for 2018 shows the ACA is failing.

A new study, published by researchers at Massachusetts General Hospital, has questioned the traditional model of cancer metastases that implicates lymph nodes in helping seed cancer cells at distant sites.

A recent analysis of cancer incidence and mortality rates across America finds that while those in rural counties are less likely to get cancer, cancer-related mortality rates are higher than in more populous areas, and this disparity is increasing over time.

The findings demonstrate why quality ratings focus heavily on managing diabetes and targeting 30-day readmission rates.

This post is part of a series of blogs illuminating aspects of racial equity in childbirth and highlighting promising practices to ensure access to a safe, empowering, healthy, and positive birth for all people.

The Government Accountability Office (GAO) recommended that CMS should take steps to prevent lower quality hospitals from qualifying for value-based bonuses, after a report by the office found that some bonuses in recent years had rewarded poorly-rated hospitals.

The incidence of multiply recurrent Clostridium difficile infection is increasing in the United States, leading to a higher demand for new treatments, according to a recent study.

Research published by Cancer Management & Research explores the efficacy of treating multiple malignancies with immune checkpoint inhibitors and programmed cell death-1 inhibitors (PD-1). The review specifically analyzes the presence of pneumonitis as an adverse event following treatment of checkpoint inhibitors.

Narrow insurance coverage has forced some patients to choose between lower premium plans and access to better quality cancer care, according to a recent report.

A study published by BloodAdvances, a Journal of the American Society of Hematology, demonstrated the potential of the 2-pronged approach in treating non-Hodgkin lymphoma, multiple myeloma, and acute myeloid leukemia.

New results from a meta-analysis reveal a decrease in the excess risk of cardiovascular events in patients with rheumatoid arthritis (RA) since the start of the 21st century.

The FDA has approved the Praxis Extended RAS Panel for genetic testing in patients with metastatic colorectal cancer (CRC). Detecting certain tumor mutations using the test could have important implications for treatment decisions.

Patients with chronic obstructive pulmonary disease (COPD) often experience chronic pain symptoms, including low physical activity, depression, and hyperinflation, that impact their everyday lives.

Biosimilar molecules have gained access to the US market, and providers and patients are steadily warming up to the idea of using these products, but challenges still exist. Here are 5 of the recent developments in the biosimilar landscape.

Treating myelodysplastic syndrome patients with luspatercept can increase hemoglobin and decrease the burden of red blood cell transfusion for more than 26 months, according to new results from a phase 2 trial.

This week, the top managed care news included Senators hearing from their constituents about the healthcare bill; a dispute with a health insurer shut down a state government for 3 days; and the FDA approved a new test for leukemias and lymphomas.

Patients with schizophrenia are at high risk of developing diabetes, particularly due to the effects of antipsychotic medications, but the results of a recently published trial indicate liraglutide can help improve glucose tolerance and body weight in prediabetic patients.

Minnesota's attorney general helped resolve a split that was a sign of the times. Top-performing hospitals increasingly find themselves on the outside of narrow networks when managed care contracts try to limit costs.

The FDA has placed 3 clinical trials of Keytruda (pembrolizumab) on hold in response to a pattern of patient deaths, according to a statement from Merck.

Coverage of our peer-reviewed research in the healthcare and mainstream press.

There is limited evidence connecting depression to the disease course of inflammatory bowel disease, according to a new study. However, Crohn's disease had a strong association.

The BreathLink device is intended to immediately identify any indications of breast cancer based on a 2-minute sample of a patient’s breath.

Lawmakers had ordered Kasich to start the process of undoing Medicaid expansion, but the Republican governor vetoed the budget language.